However, the combined analysis of BRCA1 and BRCA2 mutation carriers defined a set of eleven variants as potentially causal, which corresponded to the eleven strongest associated variants in BRCA1. This set excluded rs3814113 that was reported in the ovarian cancer GWAS [5]. This evidence concerns the gene BRCA2 and ovarian cancer.